|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | (2013.01) |
| A61K 45/06 | (2006.01) | ||
| C07D 413/06 | (2006.01) | ||
| A61K 31/437 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/505 | (2013.01) | ||
| A61K 38/06 | (2006.01) | ||
| A61K 38/12 | (2013.01) | ||
| A61K 38/12 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 51/08 | (2006.01) | ||
| A61K 31/567 | (2013.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/513 | (2013.01) | ||
| A61K 38/095 | (2019.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/567 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 38/08 | (2019.01) |
| (11) | Patento numeris | 3265127 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16759295.5 |
| Europos patento paraiškos padavimo data | 2016-02-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-02-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/019646 |
| Data | 2016-02-25 |
| (87) | Numeris | WO 2016/140867 |
| Data | 2016-09-09 |
| (30) | Numeris | Data | Šalis |
| 201562127153 P | 2015-03-02 | US |
| (72) |
MORAITIS, Andreas G. , US
BELANOFF, Joseph K. , US
|
| (73) |
Corcept Therapeutics, Inc. ,
149 Commonwealth Drive, Menlo Park CA 94025,
US
|
| (54) | MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMOR |
| MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMOR |